SCORE2 Report 13: Intraretinal Hemorrhage Changes in Eyes With Central or Hemiretinal Vein Occlusion Managed With Aflibercept, Bevacizumab or Observation. Secondary Analysis of the SCORE and SCORE2 Clinical Trials.

PubMed ID: 32828880 Author(s): Hendrick A, VanVeldhuisen PC, Scott IU, King J, Blodi BA, Ip MS, Khurana RN, Oden NL; SCORE2 Investigator Group. SCORE2 Report 13: Intraretinal hemorrhage changes in eyes with central or hemiretinal …

Alcohol Pads and Nonsterile Gloves in Preparation of Aflibercept.

PubMed ID: 32768034 Author(s): Regan KA, Gottlieb JL, Altaweel MM, Mititelu M, Blodi BA, Nork TM, Stepien KE, Chang JS. Alcohol pads and nonsterile gloves in preparation of aflibercept. Ophthalmol Retina. 2020 Aug;4(8):853-854. doi: 10.1016/j.oret.2020.04.006. …

Month 24 Outcomes After Treatment Initiation With Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal or Hemiretinal Vein Occlusion: SCORE2 Report 10: A Secondary Analysis of the SCORE2 Randomized Clinical Trial.

PubMed ID: 31600368 Author(s): Scott IU, Oden NL, VanVeldhuisen PC, Ip MS, Blodi BA, Chan CK; SCORE2 Investigator Group. Month 24 outcomes after treatment initiation with anti-vascular endothelial growth factor therapy for macular edema due …